Cerevel Therapeutics – $253.8 Million Follow-on Offering and Concurrent $345.0 Million Rule 144A Convertible Notes Offering
Rankings & accolades
Chambers USA: Capital Markets: Debt & Equity
Legal 500: Key Lawyer – Capital Markets: Equity Offerings
He has been absolutely brilliant. He is relaxed, measured, on top of all the issues and a delight to deal with.
Client Testimonial, Chambers USA